BioMedNewsBreaks – InnerScope Hearing Technologies Inc. (INND) to Present at Diamond Equity Research Emerging Growth Virtual Conference

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, today announced that its CEO Matthew Moore was invited to present at the Diamond Equity Research Emerging Growth Invitation Virtual Conference. InnerScope will be the only OTC: Pink company invited to present alongside NASDAQ-listed companies for the May 11, 2021, virtual conference. Moore is scheduled to host a virtual presentation to institutional investors at 12:20 p.m. ET, during which he will provide an overview of InnerScope’s business as a disruptive leader in the emerging DTC hearing aid device market, expected to be worth tens of billions of dollars. Moore will highlight recent corporate achievements in providing easy, convenient and affordable access to its DTC app-controlled technology for the 48 million Americans with hearing loss. Interested parties should visit https://ibn.fm/5sGdD to register for and access the live presentation.

To view the full press release, visit https://ibn.fm/W4tvP

About InnerScope Hearing Technologies Inc.

InnerScope Hearing Technologies is a manufacturer, distributor and retailer of FDA-Registered direct-to-consumer (“DTC”) app-controlled, self-adjusting hearing aids and personal sound amplifier products, doctor-formulated dietary hearing & tinnitus supplements, and assorted ear & hearing health-related products (collectively “hearing products”). Its mission is to improve the quality of life of the 70 million people in North America who suffer from hearing impairment and/or hearing-related issues. The management team of InnerScope is applying decades of industry experience and believes it is well positioned to directly benefit from the Over-the-Counter Hearing Aid Act (expected to be enacted within the next few months). InnerScope offers affordable app-controlled, self-adjusting hearing technology (www.NoHassleHearing.com) combined with its innovative point-of-sale hearing screening kiosks designed for consumers with mild-to-moderate hearing loss to purchase over-the-counter hearing aids without being seen by a hearing care professional. For more information about the company, visit www.INND.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — NextPlat Corp. (NASDAQ: NXPL, NXPLW) to Announce Q3 2025 Financial Results on Nov. 13 

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology…

1 day ago

BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Present Sapu003 Data at 2025 San Antonio Breast Cancer Symposium

Oncotelic Therapeutics (OTCQB: OTLC) a biopharmaceutical company advancing transformative cancer therapies through its PDAOAI platform…

4 days ago

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules Third Quarter 2025 Conference Call for Nov. 13 

HeartBeam (NASDAQ: BEAT), a medical technology company transforming cardiac care through personalized insights, will hold…

5 days ago

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsWire Editorial on Nanomedicine Advances 

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Nanomedicine Innovations…

5 days ago

BioMedNewsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Granted 180-Day Nasdaq Extension to Regain Minimum Bid Price Compliance

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology…

6 days ago

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission 

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, today announced it has received…

1 week ago